HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Gossetx, W. H. Articles by Beeson, W. M. Search for Related Content PubMed Articles by Gossetx, W. H. Articles by Beeson, W. M.

Value of Supplemental Lysine, Methionine, Methionine Analog, and Trace Minerals on High Urea Fattening Rations for Beef Steers^{1, 2,}

Purdue University Agricultural Experiment Station, Lafayette, Indiana

Abstract

The results from three experiments designed to study the effect of adding L-lysine, DL-methionine, methionine hydroxy analog and trace minerals in high urea fattening rations for beef steers are reported. Zinc bacitracin was also tested in one experiment. Lysine, added singly or in combination with DL-methionine was of no benefit when added to a 32f0 supplement containing all natural protein. The addition of lysine to 40, 48, 56, 64 and 72% supplements made them equivalent to the 32% control containing all natural protein, when fed on a protein-equivalent basis. When 10 gms. of lysine were fed per steer daily, one lb. of 64% supplement was equal to 2.0 lb. of 32% supplement in two of the three experiments.

Methionine improved the 64% supplement slightly, but not to the extent of that of lysine. Methionine analog was of no benefit at the 5-gm. level and gave a significant depression in rate of gain at the 10-gm. level.

Trace minerals (Mn, Fe, Cu, Co, I and Zn) were of no benefit when added to either the 32% supplement or the 64% supplement.

Zinc bacitracin fed at 80 mg. per head daily gave no improvement in daily gain or feed efficiency, but seemed to improve carcass grade.

¹ Contribution from the Department of Animal Science, Journal Paper No.1807.

² Supported in part by grants from Chas. Pfizer and Co., Terre Haute, Indiana; Dow Chemical Co., Midland, Michigan; Commercial Solvents Corporation, Terre Haute, Indiana; and E.I. du Pont de Nemours and Co., Inc., Wilmington, Delaware.